GT
Glenmede Trust Portfolio holdings
AUM
$18.6B
1-Year Return
8.78%
This Quarter Return
+23.48%
1 Year Return
+8.78%
3 Year Return
+33.81%
5 Year Return
+160.7%
10 Year Return
+249.02%
AUM
$16.4B
AUM Growth
-$5.58B
(-25%)
Cap. Flow
-$3.97B
Cap. Flow
% of AUM
-24.26%
Top 10 Holdings %
Top 10 Hldgs %
18.07%
Holding
3,460
New
284
Increased
974
Reduced
1,077
Closed
907
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$102M |
| 2 |
Lowe's Companies
LOW
|
+$89.2M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$82.8M |
| 4 |
Lennar Class A
LEN
|
+$73.6M |
| 5 |
Monster Beverage
MNST
|
+$68.5M |
Top Sells
| 1 |
Accenture
ACN
|
+$129M |
| 2 |
PayPal
PYPL
|
+$125M |
| 3 |
Microsoft
MSFT
|
+$117M |
| 4 |
Mastercard
MA
|
+$109M |
| 5 |
Trane Technologies
TT
|
+$108M |
Sector Composition
| 1 | Technology | 23.1% |
| 2 | Healthcare | 13.89% |
| 3 | Financials | 11.27% |
| 4 | Consumer Discretionary | 8.92% |
| 5 | Industrials | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
HSBC
HSBC
$239B
| $204K | ﹤0.01% |
8,820
-2,644
| -23% | -$61.2K |
|
1002
Quanterix
QTRX
$223M
| $204K | ﹤0.01% |
+7,473
| New | +$204K |
|
1003
RLI Corp
RLI
$6.15B
| $204K | ﹤0.01% |
4,980
+220
| +5% | +$9.01K |
|
1004
FibroGen
FGEN
$50.3M
| $203K | ﹤0.01% |
+201
| New | +$203K |
|
1005
Five Below
FIVE
$8.04B
| $203K | ﹤0.01% |
1,906
+1,228
| +181% | +$131K |
|
1006
FIVE9
FIVN
$2.02B
| $203K | ﹤0.01% |
1,838
-6,471
| -78% | -$715K |
|
1007
Iovance Biotherapeutics
IOVA
$876M
| $203K | ﹤0.01% |
7,430
+400
| +6% | +$10.9K |
|
1008
iShares Europe ETF
IEV
$2.35B
| $202K | ﹤0.01% |
5,000
| – | – |
|
1009
Masimo
MASI
$7.94B
| $202K | ﹤0.01% |
+888
| New | +$202K |
|
|
CHL
1010
DELISTED
China Mobile Limited
CHL
| $202K | ﹤0.01% |
6,026
+682
| +13% | +$22.9K |
|
1011
Bank of America Series L
BAC.PRL
$3.95B
| $201K | ﹤0.01% |
150
| – | – |
|
1012
US Foods
USFD
$18B
| $200K | ﹤0.01% |
10,165
-10,026
| -50% | -$197K |
|
1013
ITT
ITT
$13.9B
| $199K | ﹤0.01% |
3,400
+249
| +8% | +$14.6K |
|
|
MNTA
1014
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $199K | ﹤0.01% |
6,010
+5,149
| +598% | +$170K |
|
1015
Schwab US Dividend Equity ETF
SCHD
$72.2B
| $198K | ﹤0.01% |
11,538
+8,517
| +282% | +$146K |
|
1016
Acadia Pharmaceuticals
ACAD
$4.08B
| $195K | ﹤0.01% |
4,028
-5,753
| -59% | -$279K |
|
1017
CBIZ
CBZ
$3.13B
| $195K | ﹤0.01% |
8,166
+2,836
| +53% | +$67.7K |
|
1018
Cullen/Frost Bankers
CFR
$8.23B
| $194K | ﹤0.01% |
2,616
-3,020
| -54% | -$224K |
|
|
HRC
1019
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $194K | ﹤0.01% |
1,781
-1,010
| -36% | -$110K |
|
|
ANSS
1020
DELISTED
Ansys
ANSS
| $193K | ﹤0.01% |
662
-18
| -3% | -$5.25K |
|
1021
Scotiabank
BNS
$79.9B
| $192K | ﹤0.01% |
4,680
-456
| -9% | -$18.7K |
|
1022
Revolve Group
RVLV
$1.71B
| $192K | ﹤0.01% |
+12,971
| New | +$192K |
|
1023
Insight Enterprises
NSIT
$4.07B
| $191K | ﹤0.01% |
3,908
+3,342
| +590% | +$163K |
|
1024
Pinnacle Financial Partners
PNFP
$7.59B
| $191K | ﹤0.01% |
4,573
+191
| +4% | +$7.98K |
|
|
MYOK
1025
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $191K | ﹤0.01% |
+1,987
| New | +$191K |
|